Skip header and navigation

Refine By

1022 records – page 1 of 103.

The 6-F nitinol TrapEase inferior vena cava filter: results of a prospective multicenter trial.

https://arctichealth.org/en/permalink/ahliterature195125
Source
J Vasc Interv Radiol. 2001 Mar;12(3):299-304
Publication Type
Article
Date
Mar-2001
Author
H. Rousseau
P. Perreault
P. Otal
L. Stockx
J. Golzarian
V. Oliva
P. Reynaud
F. Raat
F. Szatmari
G. Santoro
G. Emanuelli
M. Nonent
Y. Hoogeveen
Author Affiliation
Radiology Department, CHU Rangueil, Toulouse, France. rousseau.h@chu-toulouse.fr
Source
J Vasc Interv Radiol. 2001 Mar;12(3):299-304
Date
Mar-2001
Language
English
Publication Type
Article
Keywords
Aged
Alloys
Canada
Equipment Design
Europe
Female
Follow-Up Studies
Humans
Male
Prospective Studies
Pulmonary Embolism - prevention & control
Risk
Time Factors
Vena Cava Filters - adverse effects
Venous Thrombosis - epidemiology
Abstract
The authors report the first results of a new 6-F symmetrically designed permanent nitinol inferior vena cava (IVC) filter, the Cordis TrapEase, evaluated in a multicenter prospective study with 6-months of follow-up.
A total of 65 patients (29 men, 36 women) who ranged in age from 37 to 96 years (mean age, 68 years) and who were at high risk of pulmonary embolism (PE) were enrolled in 12 centers in Europe and Canada. The study was approved by the institutional review boards at all centers. Study objectives were to evaluate filter effectiveness, filter stability, and caval occlusion. Indications for filter placement were deep vein thrombosis with recurrent thromboembolism and/or free-floating thrombus with contraindication to anticoagulation in 37 patients, and complications in achieving adequate anticoagulation in 28 patients. Follow-up included clinical examination, plain film, Doppler ultrasound, CT scan, and nuclear medicine.
The analysis of the data revealed a technical success of 95.4% (three filter-system related implantations not at the intended site, no events of filter tilting) and a clinical success of 100% at 6 months (no cases of symptomatic PE), the study primary endpoint. There were no cases (0%) of filter migration, insertion site thrombosis, filter fracture, or vessel wall perforation. During the study period, there were two cases of filter thrombosis: one case of early symptomatic thrombosis that was successfully treated in the hospital, and one case of nonsymptomatic filter thrombosis detected at 1-month follow-up, with spontaneous recanalization at 3 months. In the latter patient, some residual thrombus was still detected at 6 months. Of the study population of 65 patients, there were 23 deaths. These deaths were not related to the device or the implantation procedure but to the underlying disease process.
This study demonstrates the new nitinol permanent IVC filter to be a safe and an effective device, with a low overall complication rate, for use in patients with thromboembolic disease at high risk of PE.
PubMed ID
11287505 View in PubMed
Less detail

A 15-month evaluation of the effects of repeated subgingival minocycline in chronic adult periodontitis.

https://arctichealth.org/en/permalink/ahliterature201582
Source
J Periodontol. 1999 Jun;70(6):657-67
Publication Type
Article
Date
Jun-1999
Author
D. van Steenberghe
B. Rosling
P O Söder
R G Landry
U. van der Velden
M F Timmerman
E F McCarthy
G. Vandenhoven
C. Wouters
M. Wilson
J. Matthews
H N Newman
Author Affiliation
Catholic University, Leuven, Belgium.
Source
J Periodontol. 1999 Jun;70(6):657-67
Date
Jun-1999
Language
English
Publication Type
Article
Keywords
Adult
Aggregatibacter actinomycetemcomitans - drug effects
Analysis of Variance
Anti-Bacterial Agents - administration & dosage
Campylobacter - drug effects
Canada
Chronic Disease
Colony Count, Microbial
Dental Plaque Index
Dental Scaling
Double-Blind Method
Eikenella corrodens - drug effects
Europe
Female
Fusobacterium nucleatum - drug effects
Humans
Longitudinal Studies
Male
Middle Aged
Minocycline - administration & dosage
Ointments
Periodontal Index
Periodontal Pocket - drug therapy - microbiology
Periodontitis - drug therapy - microbiology
Porphyromonas gingivalis - drug effects
Prevotella intermedia - drug effects
Statistics, nonparametric
Treatment Outcome
Treponema - drug effects
Abstract
A double-blind, randomized, parallel, comparative study was designed to evaluate the long-term safety and efficacy of subgingivally administered minocycline ointment versus a vehicle control.
One hundred four patients (104) with moderate to severe adult periodontitis (34 to 64 years of age; mean 46 years) were enrolled in the study. Following scaling and root planing, patients were randomized to receive either 2% minocycline ointment or a matched vehicle control. Study medication was administered directly into the periodontal pocket with a specially designed, graduated, disposable applicator at baseline; week 2; and at months 1, 3, 6, 9, and 12. Scaling and root planing was repeated at months 6 and 12. Standard clinical variables (including probing depth and attachment level) were evaluated at baseline and at months 1, 3, 6, 9, 12, and 15. Microbiological sampling using DNA probes was done at baseline; at week 2; and at months 1, 3, 6, 9, 12, and 15.
Both treatment groups showed significant and clinically relevant reductions in the numbers of each of the 7 microorganisms measured during the entire 15-month study period. When differences were detected, sites treated with minocycline ointment always produced statistically significantly greater reductions than sites which received the vehicle control. For initial pockets > or =5 mm, a mean reduction in probing depth of 1.9 mm was seen in the test sites, versus 1.2 mm in the control sites. Sites with a baseline probing depth > or =7 mm and bleeding index >2 showed an average of 2.5 mm reduction with minocycline versus 1.5 mm with the vehicle. Gains in attachment (0.9 mm and 1.1 mm) were observed in minocycline-treated sites, with baseline probing depth > or =5 mm and > or =7 mm, respectively, compared with 0.5 mm and 0.7 mm gain at control sites. Subgingival administration of minocycline ointment was well tolerated.
Overall, the results demonstrate that repeated subgingival administration of minocycline ointment in the treatment of adult periodontitis is safe and leads to significant adjunctive improvement after subgingival instrumentation in both clinical and microbiologic variables over a 15-month period.
PubMed ID
10397521 View in PubMed
Less detail

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis.

https://arctichealth.org/en/permalink/ahliterature144028
Source
Clin Exp Immunol. 2010 Apr;160(1):106-12
Publication Type
Article
Date
Apr-2010
Author
L. Chatenoud
S. You
H. Okada
C. Kuhn
B. Michaud
J-F Bach
Author Affiliation
Université Paris Descarte, Paris, France. lucienne.chatenoud@inserm.fr
Source
Clin Exp Immunol. 2010 Apr;160(1):106-12
Date
Apr-2010
Language
English
Publication Type
Article
Keywords
Adolescent
Animals
Autoantigens - immunology
Bacteria - immunology
Canada - epidemiology
Child
Diabetes Mellitus, Type 1 - immunology - therapy
Europe - epidemiology
Humans
Hygiene
Hypersensitivity - immunology
Immunosuppression - methods
Immunotherapy - methods
Infection - immunology - microbiology
Mice
Pancreatitis - immunology - microbiology
Toll-Like Receptors - agonists
Young Adult
Abstract
Insulin-dependent (type 1) diabetes is a prototypic organ-specific autoimmune disease resulting from the selective destruction of insulin-secreting beta cells within pancreatic islets of Langerhans by an immune-mediated inflammation involving autoreactive CD4(+) and CD8(+) T lymphocytes which infiltrate pancreatic islets. Current treatment is substitutive, i.e. chronic use of exogenous insulin which, in spite of significant advances, is still associated with major constraints (multiple daily injections, risks of hypoglycaemia) and lack of effectiveness over the long term in preventing severe degenerative complications. Finding a cure for autoimmune diabetes by establishing effective immune-based therapies is a real medical health challenge, as the disease incidence increases steadily in industrialized countries. As the disease affects mainly children and young adults, any candidate immune therapy must therefore be safe and avoid a sustained depression of immune responses with the attendant problems of recurrent infection and drug toxicity. Thus, inducing or restoring immune tolerance to target autoantigens, controlling the pathogenic response while preserving the host reactivity to exogenous/unrelated antigens, appears to be the ideal approach. Our objective is to review the major progress accomplished over the last 20 years towards that aim. In addition, we would like to present another interesting possibility to access new preventive strategies based on the 'hygiene hypothesis', which proposes a causal link between the increasing incidence of autoimmune diseases, including diabetes, and the decrease of the infectious burden. The underlying rationale is to identify microbial-derived compounds mediating the protective activity of infections which could be developed therapeutically.
Notes
Cites: J Immunol. 2000 Jun 1;164(11):5683-810820244
Cites: Clin Exp Immunol. 2010 Apr;160(1):1-920415844
Cites: Lancet. 2000 Aug 12;356(9229):545-910950231
Cites: Diabetologia. 2000 Aug;43(8):1000-410990077
Cites: J Immunol. 2000 Dec 1;165(11):6148-5511086048
Cites: Annu Rev Immunol. 2001;19:131-6111244033
Cites: J Immunol. 2001 Jul 15;167(2):1081-911441119
Cites: Lancet. 2001 Nov 24;358(9295):1749-5311734230
Cites: Nature. 2002 Apr 11;416(6881):603-711948342
Cites: Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5539-4411943868
Cites: N Engl J Med. 2002 May 30;346(22):1685-9112037147
Cites: N Engl J Med. 2002 May 30;346(22):1740-212037155
Cites: N Engl J Med. 2002 Sep 19;347(12):911-2012239261
Cites: Vaccine. 2003 Feb 14;21(9-10):836-4212547591
Cites: Int Immunopharmacol. 2003 Mar;3(3):417-2512639819
Cites: Science. 1984 Mar 30;223(4643):1362-76367043
Cites: Lancet. 1986 Jul 19;2(8499):119-242873396
Cites: Diabetes. 1986 Aug;35(8):855-603525284
Cites: J Exp Med. 1989 May 1;169(5):1669-802523954
Cites: BMJ. 1989 Nov 18;299(6710):1259-602513902
Cites: J Autoimmun. 1989 Dec;2(6):759-762533502
Cites: Chem Pharm Bull (Tokyo). 1992 Apr;40(4):1004-61525928
Cites: Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):123-78278351
Cites: Endocr Rev. 1994 Aug;15(4):516-427988484
Cites: Diabetes Metab. 1996 Oct;22(5):341-88896996
Cites: J Exp Med. 1996 Nov 1;184(5):2049-538920894
Cites: J Immunol. 1997 Mar 15;158(6):2947-549058834
Cites: Immunology. 1962 May;5:378-8813887798
Cites: Nat Med. 2005 Feb;11(2):138-4515654326
Cites: N Engl J Med. 2005 Jun 23;352(25):2598-60815972866
Cites: J Exp Med. 2005 Oct 17;202(8):1131-916230478
Cites: J Exp Med. 2005 Nov 7;202(9):1171-716260486
Cites: Diabetes. 2006 Jan;55(1):179-8516380491
Cites: J Neuroimmunol. 2006 Mar;172(1-2):94-10316360885
Cites: Immunol Rev. 2006 Aug;212:185-20216903915
Cites: J Med Chem. 2006 Oct 5;49(20):6000-1417004714
Cites: Immunobiology. 2006;211(10):767-7717113914
Cites: Nat Rev Immunol. 2007 May;7(5):353-6417457343
Cites: Pediatr Diabetes. 2007 Oct;8 Suppl 6:6-1417727380
Cites: J Clin Invest. 2007 Dec;117(12):3857-6718060033
Cites: N Engl J Med. 2008 Feb 14;358(7):676-8818272891
Cites: J Immunol. 2008 Mar 1;180(5):2863-7518292508
Cites: Lancet. 2008 May 24;371(9626):1777-8218502302
Cites: N Engl J Med. 2008 Oct 30;359(18):1909-2018843118
Cites: Lancet. 2008 Nov 15;372(9651):1746-5518814906
Cites: Nat Rev Endocrinol. 2009 Apr;5(4):219-2619352320
Cites: Lancet. 2009 Jun 13;373(9680):2027-3319481249
Cites: Diabetes Care. 2009 Nov;32(11):2036-4019690081
Cites: N Engl J Med. 2009 Nov 26;361(22):2143-5219940299
Cites: Eur J Biochem. 2000 Jun;267(11):3370-710824125
PubMed ID
20415859 View in PubMed
Less detail

The 1974 Gordon Richards Memorial Lecture: trends in the organization of cancer services.

https://arctichealth.org/en/permalink/ahliterature251715
Source
J Can Assoc Radiol. 1975 Dec;26(4):223-30
Publication Type
Article
Date
Dec-1975
Author
T A Watson
Source
J Can Assoc Radiol. 1975 Dec;26(4):223-30
Date
Dec-1975
Language
English
Publication Type
Article
Keywords
Canada
Education, Medical, Undergraduate
Europe
Health planning
History, 20th Century
Humans
Neoplasms - history - radiotherapy
Radiotherapy - history
Research
Abstract
The development of cancer programs and organizations in Canada is traced from their beginnings until the present time, and tribute is paid to our pioneers, of whom Dr. Richards was an outstanding example in this field. Although provinical cancer control measures vary, there is a marked similarity among some, so that they can be categorized into two or three patterns. The desirable requirements for the establishment and progressive development of cancer centres is described together with their relationship to increasing integration of teaching and research activities. An attempt is made to predict the future pattern of our "cancer clinic" system in which there will be increasing reliance on an interdisciplinary approach.
PubMed ID
770478 View in PubMed
Less detail

AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons.

https://arctichealth.org/en/permalink/ahliterature161050
Source
J Am Coll Cardiol. 2007 Oct 2;50(14):1400-33
Publication Type
Article
Date
Oct-2-2007

About the concept of the "dangerous individual" in 19th-century legal psychiatry.

https://arctichealth.org/en/permalink/ahliterature248925
Source
Int J Law Psychiatry. 1978 Feb;1(1):1-18
Publication Type
Article
Date
Feb-1978
Author
M. Foucault
Source
Int J Law Psychiatry. 1978 Feb;1(1):1-18
Date
Feb-1978
Language
English
Publication Type
Article
Keywords
Canada
Dangerous Behavior
Europe
Forensic Psychiatry - history
History, 19th Century
Humans
Terminology as Topic
Violence
PubMed ID
374291 View in PubMed
Less detail

Absence of indigenous specific West Nile virus antibodies in Tyrolean blood donors.

https://arctichealth.org/en/permalink/ahliterature134646
Source
Eur J Clin Microbiol Infect Dis. 2012 Jan;31(1):77-81
Publication Type
Article
Date
Jan-2012
Author
S T Sonnleitner
J. Simeoni
E. Schmutzhard
M. Niedrig
F. Ploner
H. Schennach
M P Dierich
G. Walder
Author Affiliation
Hygiene and Medical Microbiology, Medical University Innsbruck, Fritz Pregl Straße 1-3/III, Innsbruck, Austria. sissyson@gmx.at
Source
Eur J Clin Microbiol Infect Dis. 2012 Jan;31(1):77-81
Date
Jan-2012
Language
English
Publication Type
Article
Keywords
Adult
Antibodies, Viral - blood
Blood Donors
Child, Preschool
Encephalitis Viruses, Tick-Borne - immunology
Enzyme-Linked Immunosorbent Assay
Europe
False Positive Reactions
Female
Humans
Italy
Male
Middle Aged
Neutralization Tests
West Nile Fever - diagnosis - epidemiology - virology
West Nile virus - immunology
Abstract
In the last several years, West Nile virus (WNV) was proven to be present especially in the neighboring countries of Austria, such as Italy, Hungary, and the Czech Republic, as well as in eastern parts of Austria, where it was detected in migratory and domestic birds. In summer 2010, infections with WNV were reported from Romania and northern Greece with about 150 diseased and increasingly fatal cases. We tested the sera of 1,607 blood donors from North Tyrol (Austria) and South Tyrol (Italy) for antibodies against WNV by using IgG enzyme-linked immunosorbent assay (ELISA). Initial results of the ELISA tests showed seroprevalence rates of 46.2% in North Tyrol and 0.5% in South Tyrol, which turned out to be false-positive cross-reactions with antibodies against tick-borne encephalitis virus (TBEV) by adjacent neutralization assays. These results indicate that seropositivity against WNV requires confirmation by neutralization assays, as cross-reactivity with TBEV is frequent and because, currently, WNV is not endemic in the study area.
PubMed ID
21556676 View in PubMed
Less detail

Abstracts. Seventh annual meeting. The European Society for Paediatric Haematology and Immunology. Oslo, Norway, June 11-13, 1979.

https://arctichealth.org/en/permalink/ahliterature41315
Source
Pediatr Res. 1979 Aug;13(8):948-57
Publication Type
Conference/Meeting Material
Date
Aug-1979

Adherence to colorectal cancer screening. A brief overview.

https://arctichealth.org/en/permalink/ahliterature214286
Source
Ann N Y Acad Sci. 1995 Sep 30;768:292-5
Publication Type
Article
Date
Sep-30-1995
Author
S W Vernon
Author Affiliation
School of Public Health, University of Texas-Houston 77225, USA.
Source
Ann N Y Acad Sci. 1995 Sep 30;768:292-5
Date
Sep-30-1995
Language
English
Publication Type
Article
Keywords
Canada
Colorectal Neoplasms - diagnosis - prevention & control
Europe
Health Surveys
Humans
Mass Media
Mass Screening
Occupational Health Services
Patient compliance
Sigmoidoscopy
United States
PubMed ID
8526370 View in PubMed
Less detail

1022 records – page 1 of 103.